44 results on '"Bonenfant, Debora"'
Search Results
2. Abstract 3449: Development of MRT-2359, an orally bioavailable GSPT1 molecular glue degrader, for the treatment of lung cancers with MYC-induced translational addiction
3. Supplementary Table 1 from Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
4. Supplementary Table 1 from Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
5. Supplementary Table 2 from Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
6. Data from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
7. Supplementary Figure 3 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
8. Supplementary Table 7 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
9. Supplementary Figure 1 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
10. Supplementary Table 2 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
11. Supplementary Figures from Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
12. Supplementary Figure 4 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
13. Supplementary Figure 6 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
14. Supplementary Table 2 from Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
15. Supplementary Figure 2 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
16. Supplementary Table 1 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
17. Data from Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
18. Supplementary Figures from Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
19. Supplementary Methods and Materials from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
20. Supplementary Figure Legends 1-6,Table Legends 1-7 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
21. Supplementary Table 5 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
22. Supplementary Table 6 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
23. Supplementary Figure 5 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
24. Supplementary Table 4 from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
25. Supplementary Table 3B from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
26. Supplementary Table 3A from Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
27. A novel HERC4-dependent glue degrader targeting STING
28. BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma
29. Abstract 3929: Identification of MRT-2359 a potent, selective and orally bioavailable GSPT1-directed molecular glue degrader (MGD) for the treatment of cancers with Myc-induced translational addiction
30. Protein Tyrosine Phosphatase SHP2 Controls Interleukin-8 Expression in Breast Cancer Cells
31. Abstract LBA004: Identification of GSPT1-directed molecular glue degrader (MGD) for the treatment of Myc-driven breast cancer
32. BET bromodomain inhibitors regulate keratinocyte plasticity
33. Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms
34. Therapeutic assessment of targeting ASNS combined with L-Asparaginase treatment in solid tumors and investigation of resistance mechanisms
35. Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC
36. Author response: Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC
37. TMEM 41B is a novel regulator of autophagy and lipid mobilization
38. Inhibition of DDR 1‐ BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
39. Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition
40. CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency
41. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer
42. Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
43. Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
44. Identification of the rapamycin‐sensitive phosphorylation sites within the Ser/Thr‐rich domain of the yeast Npr1 protein kinase
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.